HOME >> BIOLOGY >> NEWS
Radiation alone after surgery still the standard for head and neck cancer

A preliminary study has found no advantage to adding chemotherapy to radiation after surgery for treating advanced head and neck cancer patients. The findings of the research, to be presented at the American Society of Clinical Oncology meeting May 18, appear to set aside earlier data suggesting that a combination of chemotherapy and radiation would improve the odds of staying cancer-free after surgery. Results are published in abstract # 903 in the ASCO Program/Proceedings.

Recurrence and spread of head and neck cancer is common and fewer than half of these patients are expected to survive past five years. "Early studies suggested that combining certain chemotherapy drugs and radiation may have a synergistic effect in these patients," says Arlene Forastiere, M.D., professor of oncology and otolaryngology at the Johns Hopkins Kimmel Cancer Center and medical oncology co-chair of the study. "Our current study shows that adding the chemotherapy drug cisplatin to standard radiation treatment does not significantly reduce recurrence."

The study evaluated 407 patients who had surgery to remove their cancer and were at high risk for recurrence. After surgery, patients in one group received radiation alone and, in a second group, a combination of cisplatin and radiation.

In a preliminary analysis after two years, researchers found no significant difference between the two groups in the percentage of patients remaining cancer-free. The cancer recurred in 26 percent of patients receiving radiation alone and in 20 percent of those receiving chemotherapy and radiation. There also was no significant difference between the two groups in overall survival 63 percent in the combination therapy group versus 57 percent who received radiation only.

Just over half (58 percent) of the patients getting combination therapy were able to take all three doses of chemotherapy. The others did not tolerate the full dose. These patients experienced more s
'"/>

Contact: Vanessa Wasta
wastava@jhmi.edu
410-955-1287
Johns Hopkins Medical Institutions
18-May-2002


Page: 1 2

Related biology news :

1. Dazzling new light source opens at Stanford Synchrotron Radiation Laboratory
2. Radiation therapy targets cancer cells on two fronts, Science study says
3. Radiation-resistant organism reveals its defense strategies
4. Stanford Synchrotron Radiation Lab receives $6 million grant to decipher protein structures
5. No More Running Blind In A Maze-The Laboratory Rat Genetic And Radiation Hybrid Map Is Here
6. Mixing Radiation, Minerals, Toxic Waste Could Be Cleanup Boon -- Or Kaboom
7. UV Radiation Induces Vitamin A Deficiency In Skin
8. Combining Angiostatin With Radiation Enhances Anti-Cancer Effects Of Each
9. Amphibian Mortality Due To UV Radiation
10. Study Shows Hereditary Legacy Of Radiation Exposure
11. Geologist Finds Hidden Patterns Of Diversification In Ordovician Radiation

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2018)... ... December 04, 2018 , ... Biolytic Lab ... Dr. Oligo 192c, built on Biolytic’s Molecule Synthesis Platform. , Now restructured ... to become the world’s fastest in oligonucleotide synthesis, the 192c incorporates a multitude ...
(Date:11/27/2018)... , ... November 27, 2018 , ... ... welcomes David Pepe, P.E., as Chief Operating Officer (COO). Dave joins the ... and direct the company’s internal functions. Dave will also serve in a ...
(Date:11/27/2018)... ... November 27, 2018 , ... ... companies have worked together to integrate the LabArchives Classroom Edition with Current Protocols ... offering will be available beginning January of 2019. , The integration ...
Breaking Biology News(10 mins):
(Date:11/7/2018)... ... November 07, 2018 , ... Since September of ... increase awareness of the adult tissue stem cell counting problem in stem cell ... company is intensifying this effort with new educational publications and presentations at clinical ...
(Date:11/6/2018)... ... November 06, 2018 , ... ... clinical trial data collection and management. TrialKit ™, an eClinical platform, has ... devices can quickly and easily sign in to the app via facial recognition ...
(Date:11/5/2018)... ... November 05, 2018 , ... ... company backed by Siemens Healthineers and several healthcare VC firms announces at Distributed ... and making a history by purchasing tokens and obtaining its first radiology interpretations, ...
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed a non-exclusive ... effector code technology for applications in advancing research in epigenetic technology. , ... discovery in 2009, the efficacy of TAL effector-based DNA targeting has been established ...
Breaking Biology Technology:
Cached News: